These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

669 related articles for article (PubMed ID: 7554481)

  • 21. Circulating HIV-specific CD8+ cytotoxic T cells express CD38 and HLA-DR antigens.
    Ho HN; Hultin LE; Mitsuyasu RT; Matud JL; Hausner MA; Bockstoce D; Chou CC; O'Rourke S; Taylor JM; Giorgi JV
    J Immunol; 1993 Apr; 150(7):3070-9. PubMed ID: 8454874
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Production of CD8+ T cell nonlytic suppressive factors by CD28, CD38, and HLA-DR subpopulations.
    Jiang JQ; Balasubramanian S; Hawley-Foss NC; Badley AD; Rosenthal KL; Copeland KF
    AIDS Res Hum Retroviruses; 2003 Jun; 19(6):497-502. PubMed ID: 12882659
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Naïve and memory CD4+ T cells and T cell activation markers in HIV-1 infected children on HAART.
    Resino S; Navarro J; Bellón JM; Gurbindo D; León JA; Muñoz-Fernández MA
    Clin Exp Immunol; 2001 Aug; 125(2):266-73. PubMed ID: 11529919
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Virus burden in long-term survivors of human immunodeficiency virus (HIV) infection is a determinant of anti-HIV CD8+ lymphocyte activity.
    Ferbas J; Kaplan AH; Hausner MA; Hultin LE; Matud JL; Liu Z; Panicali DL; Nerng-Ho H; Detels R; Giorgi JV
    J Infect Dis; 1995 Aug; 172(2):329-39. PubMed ID: 7622874
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Activation and cell cycle antigens in CD4+ and CD8+ T cells correlate with plasma human immunodeficiency virus (HIV-1) RNA level in HIV-1 infection.
    Orendi JM; Bloem AC; Borleffs JC; Wijnholds FJ; de Vos NM; Nottet HS; Visser MR; Snippe H; Verhoef J; Boucher CA
    J Infect Dis; 1998 Nov; 178(5):1279-87. PubMed ID: 9780247
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alterations in the immune response of human immunodeficiency virus (HIV)-infected subjects treated with an HIV-specific protease inhibitor, ritonavir.
    Kelleher AD; Carr A; Zaunders J; Cooper DA
    J Infect Dis; 1996 Feb; 173(2):321-9. PubMed ID: 8568292
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased HLA-DR expression on peripheral blood monocytes in subsets of subjects with primary HIV infection is associated with elevated CD4 T-cell apoptosis and CD4 T-cell depletion.
    Gascon RL; Narváez AB; Zhang R; Kahn JO; Hecht FM; Herndier BG; McGrath MS
    J Acquir Immune Defic Syndr; 2002 Jun; 30(2):146-53. PubMed ID: 12045676
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of CD28 and CD38 by CD8+ T lymphocytes in HIV-1 infection correlates with markers of disease severity and changes towards normalization under treatment. The Swiss HIV Cohort Study.
    Bürgisser P; Hammann C; Kaufmann D; Battegay M; Rutschmann OT
    Clin Exp Immunol; 1999 Mar; 115(3):458-63. PubMed ID: 10193418
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lack of selective V beta deletion in CD4+ or CD8+ T lymphocytes and functional integrity of T-cell repertoire during acute HIV syndrome.
    Cossarizza A; Ortolani C; Mussini C; Guaraldi G; Mongiardo N; Borghi V; Barbieri D; Bellesia E; Franceschini MG; De Rienzo B
    AIDS; 1995 Jun; 9(6):547-53. PubMed ID: 7662191
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fuzhengpaidu granule regulates immune activation molecules CD38 and human leukocyte antigen-D related on CD4+ and CD8+ T cells in patients with acquired immunodeficiency syndrome/human immunodeficiency virus.
    Jiang F; Zhang R; Gu Z; Zhang H; Guo H; Deng X; Liang J
    J Tradit Chin Med; 2013 Aug; 33(4):439-43. PubMed ID: 24187862
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunophenotypic characterization of peripheral T lymphocytes in Mycobacterium tuberculosis infection and disease.
    Rodrigues DS; Medeiros EA; Weckx LY; Bonnez W; Salomão R; Kallas EG
    Clin Exp Immunol; 2002 Apr; 128(1):149-54. PubMed ID: 11982602
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Highly active antiretroviral therapy during early HIV infection reverses T-cell activation and maturation abnormalities. Swiss HIV Cohort Study.
    Bisset LR; Cone RW; Huber W; Battegay M; Vernazza PL; Weber R; Grob PJ; Opravil M
    AIDS; 1998 Nov; 12(16):2115-23. PubMed ID: 9833852
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Similarity of expression of activation markers and CD28 on gamma delta and alpha beta-receptor T cells in HIV infection.
    Jouen-Beades F; Gilbert D; Ramzaoui S; Borsa-Lebas F; Humbert G; Tron F
    Clin Immunol Immunopathol; 1996 May; 79(2):189-93. PubMed ID: 8620625
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CD8+,CD38+ lymphocyte percent: a useful immunological marker for monitoring HIV-1-infected patients.
    Mocroft A; Bofill M; Lipman M; Medina E; Borthwick N; Timms A; Batista L; Winter M; Sabin CA; Johnson M; Lee CA; Phillips A; Janossy G
    J Acquir Immune Defic Syndr Hum Retrovirol; 1997 Feb; 14(2):158-62. PubMed ID: 9052725
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activation and differentiation antigens on T cells of healthy, at-risk, and HIV-infected children.
    Plaeger-Marshall S; Hultin P; Bertolli J; O'Rourke S; Kobayashi R; Kobayashi AL; Giorgi JV; Bryson Y; Stiehm ER
    J Acquir Immune Defic Syndr (1988); 1993 Sep; 6(9):984-93. PubMed ID: 7688045
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Major expansions of select CD8+ subsets in acute Epstein-Barr virus infection: comparison with chronic human immunodeficiency virus disease.
    Lynne JE; Schmid I; Matud JL; Hirji K; Buessow S; Shlian DM; Giorgi JV
    J Infect Dis; 1998 Apr; 177(4):1083-7. PubMed ID: 9534988
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunological benefits of antiretroviral therapy in very early stages of asymptomatic chronic HIV-1 infection.
    Plana M; García F; Gallart T; Tortajada C; Soriano A; Palou E; Maleno MJ; Barceló JJ; Vidal C; Cruceta A; Miró JM; Gatell JM
    AIDS; 2000 Sep; 14(13):1921-33. PubMed ID: 10997396
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunophenotyping of blood lymphocytes at birth, during childhood, and during adulthood in HIV-1-uninfected Ethiopians.
    Tsegaye A; Wolday D; Otto S; Petros B; Assefa T; Alebachew T; Hailu E; Adugna F; Measho W; Dorigo W; Fontanet AL; van Baarle D; Miedema F
    Clin Immunol; 2003 Dec; 109(3):338-46. PubMed ID: 14697749
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [T-lymphocyte immune in HIV-infected people and AIDS patients in China].
    Li T; Qiu Z; Wang A; Sheng R
    Zhonghua Yi Xue Za Zhi; 2002 Oct; 82(20):1391-5. PubMed ID: 12509921
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The immunopathogenesis of retroviral diseases: no immunophenotypic alterations in T, B, and NK cell subsets in SIVmac239-challenged rhesus macaques protected by SIV delta nef vaccination.
    Giorgi JV; Hultin LE; Desrosiers RC
    J Med Primatol; 1996 Jun; 25(3):186-91. PubMed ID: 8892039
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.